[最近在开发疫苗的进展,以对抗由arenaviruses引起的出血性发烧]

相关实验视频

Updated: Jul 9, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.0K

Mathieu Mateo1, Sylvain Baize1

  • 1Institut Pasteur, Université Paris Cité, Unité de biologie des infections virales émergentes, Paris, France - Centre international de recherche en infectiologie (CIRI), université de Lyon, Inserm U1111, école normale supérieure de Lyon, université Lyon 1, CNRS UMR5308, 69-007, Lyon, France.

Medecine sciences : M/S
|November 29, 2023
PubMed
概括

阿雷纳病毒在全球范围内引起致命的出血性发烧,目前还没有获得许可的疫苗. 本次审查强调了关键的疫苗候选人,包括麻疹-拉萨疫苗和多功能MOPEVAC平台,为未来的治疗提供了希望.

更多相关视频

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment08:34

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment

Published on: March 2, 2016

9.6K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.2K

相关概念视频

Cross-reactivity00:42

Cross-reactivity

Overview
31.1K